Moreover, TGF-β1-enriched conditioned media generated using parental breast cancer cells that are triple-negative and estrogen receptor-positive, as well as their resistant counterparts, activate the p44/42 MAPK signaling pathway, which can enhance drug resistance and promote the CAF phenotype in dermal fibroblast. The gene discussed is TGFB1; the disease is breast carcinoma.